Administration of 15-methyl-prostaglandin F2alpha as a pre-operative means of cervical dilatation.
D000032:Abortion, Therapeutic; D002404:Catheterization; D002584:Cervix Uteri / Q000187:drug effects*; D003967:Diarrhea / Q000139:chemically induced; D004106:Dilatation; D005113:Extraction, Obstetrical; D005260:Female; D006801:Humans; D007267:Injections; D007273:Injections, Intramuscular; D011247:Pregnancy; D011300:Preoperative Care; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D014599:Uterus; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins